Specialized compounding in community pharmacies: Organizational perspective

Journal of the American Pharmacists Association

Volumn 50, Issue 3, 2010, Pages 354-361

  Giam, Jennifer Ann ^a   McLachlan, Andrew J ^a,b   Krass, Ines ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ANZAC Research Institute   (Australia)

Author keywords

Compounding (extemporaneous); Organization theory; Pharmacy services

Indexed keywords

ARTICLE; AUSTRALIA; CROSS-SECTIONAL STUDY; DRUG FORMULATION; ECONOMICS; HEALTH CARE QUALITY; HUMAN; ORGANIZATION AND MANAGEMENT; PHARMACY;

AUSTRALIA; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; DRUG COMPOUNDING; HUMANS; QUALITY OF HEALTH CARE;

EID: 77955293001     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.09025     Document Type: Article

References (27)

1. Pharmaceutical Society of Australia. Compounding. In: Professional practice standards. Version 3. Canberra, Australia: Pharmaceutical Society of Australia; 2006:77-83.
2. Slezak M. The roots of modern pharmacy practice. Am Drug. 1996;213:32-64.
3. Pappas A. Extemporaneous dispensing: opinions of Victorian community pharmacists. Aust J Hosp Pharm. 1999;29:196-201.
4. McPherson T, Fontane P, Jackson K, et al. Prevalence of compounding in independent community pharmacy practice. J Am Pharm Assoc. 2007;46:568-73.
5. U.S. Food and Drug Administration. Federal and state role in pharmacy compounding and reconstitution: exploring the right mix to protect patients. Accessed at www.fda.gov/NewsEvents/Testimony/ucm115010.htm, February 1, 2009.
6. Giam JA, McLachlan AJ, Krass I. Specialised compounding: practices and opinions of Australian community pharmacists. J Pharm Pract Res. 2007;37:260-4.
7. Treadway AK, Craddock D, Leff R. Practices of pharmacies that compound extemporaneous formulations. Am J Health Syst Pharm. 2007;64:1403-9.
8. Yancey V, Yakimo R, Perry A, et al. Perceptions of pharmaceutical care among pharmacists offering compounding services. J Am Pharm Assoc. 2008;48:508-14.
9. Berbatis C, Sunderland VB, Mills C, et al. National pharmacy database project. Accessed at www.guild.org.au/uploaded-files/Research-and-Development- Grants-Program/Projects/2001-056-fr.pdf, June 17, 2005.
10. Dunphy D, Palmer I, Benrimoj SI, et al. Final report: the shape of our future: Change Management and Community Pharmacy Project. Accessed at www.guild.org.au/uploadedfiles/Research-and-Development-Grants-Program/Projects/ 2003-530-fr1.pdf, April 11, 2005.
11. Roberts A, Benrimoj SI, Chen TF, et al. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42:861-8.
12. Doucette WR, Koch YD. An exploratory study of community pharmacy practice change. J Am Pharm Assoc. 2000;40:384-91.
13. Roberts A, Benrimoj SI, Chen T, et al. An investigation into business and professional facilitators for change for the pharmacy profession in light of the third Guild/Government Agreement. Accessed at www.guild.org.au/ uploadedfiles/Research-and-Development-Grants-Program/Projects/2001-070-es.pdf, December 11, 2007.
14. Roberts AS, Benrimoj SIC, Chen TF, et al. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm. 2005;1:546-64.
15. Hatch MJ, Cunliffe AL. Organization theory: modern, symbolic, and postmodern perspectives. 2nd ed. New York: Oxford University Press; 2006;4-8, 19-20, 115-6
16. Scott WR. Organizations: rational, natural, and open systems. 5th ed. Upper Saddle River, NJ: Prentice Hall; 2003:7-24
17. Zacker C, Mucha L. Institutional and contingency approaches to the reprofessionalization of pharmacy. Am J Health Syst Pharm. 1998;55:1302-5.
18. d'Amboise G, Muldowney M. Management theory for small business: attempts and requirements. Acad Manage Rev. 1988;13:226-40.
19. Merz G, Sauber M. Profiles of managerial activities in small firms. Strategic Management Journal. 1995;16:551-64.
20. National Coordinating Committee on Therapeutic Goods. A discussion paper on regulation of extemporaneously prepared medicines in non-hospital pharmacies. Accessed at www.tga.gov.au/meds/extempcomp2.htm, April 14, 2008.
21. Pharmacy Compounding Accreditation Board. About PCAB. Accessed at www.pcab.info/about-pcab.shtml, August 19, 2007.
22. Pharmaceutical Inspection Convention, Pharmaceutical Inspection Co-operation Scheme. PIC/S guide to good practices for preparation of medicinal products in healthcare establishments. Accessed at www.picscheme.org/publis/ guides/PE-010-3%20-Revised-GPP-Guide.pdf, April 3, 2008.
23. Holland R, Nimmo C. Transitions, part 1: beyond pharmaceutical care. Am J Health Syst Pharm. 1999;56:1758-64.
24. Zacker C, Mucha L. Institutional and contingency approaches to the reprofessionalization of pharmacy. Am J Health Syst Pharm. 1998;55:1302-5.
25. Roberts AS, Benrimoj SI, Chen TF, et al. Implementing cognitive services in community pharmacy: a review of models and frameworks for change. Int J Pharm Pract. 2006;14:105-14.
26. Rossing C, Hansen E, Krass I. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacists. J Soc Adm Pharm. 2001;19:55-64.
27. Ruston A. Achieving re-professionalisation: factors that influence the adoption of an 'extended role' by community pharmacists: a national survey. J Soc Adm Pharm. 2001;18:103-9.